Connection
Eric Simoes to Palivizumab
This is a "connection" page, showing publications Eric Simoes has written about Palivizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.374 |
|
|
|
-
Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
Score: 0.066
-
Feltes TF, Simoes E. Palivizumab prophylaxis in haemodynamically significant congenital heart disease. Arch Dis Child. 2005 Aug; 90(8):875-7; author reply 875-7.
Score: 0.058
-
Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis--the story so far. Respir Med. 2002 Apr; 96 Suppl B:S15-24.
Score: 0.046
-
Simoes EA. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res. 2002; 3 Suppl 1:S26-33.
Score: 0.045
-
Simoes EA. Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med. 2001 Mar; 163(3 Pt 2):S14-7.
Score: 0.043
-
Simoes EA. Immunoprophylaxis of respiratory syncytial virus infection. Indian Pediatr. 2000 Mar; 37(3):243-7.
Score: 0.040
-
Simoes EA. Respiratory syncytial virus infection. Lancet. 1999 Sep 04; 354(9181):847-52.
Score: 0.038
-
Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics). Pediatr Ann. 1999 Aug; 28(8):507-14.
Score: 0.038